UNSPSC 51142040: Ethoheptazine hydrochloride

This classification denotes an opioid receptor agonist with the molecular formula C16H23NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8KYO8O8JNO, chemically known as 1h-azepine-4-carboxylic acid, hexahydro-1-methyl-4-phenyl-, ethyl ester, hydrochloride (1:1), but more generally known as ethoheptazine hydrochloride, which bears US NIH Compound Identifier 6469. European Medicines Agency schedules ethoheptazine hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07280MIG.

Most nations, for tariff purposes, schedule ethoheptazine hydrochloride under HS 29339930. SMILES: CCOC(=O)C1(CCCN(CC1)C)C2CCCCC2.CL.

UNSPSC 51142040 Ethoheptazine hydrochloride is a Commodity code that in practice captures pharmaceutical procurement by state and local health agencies, though the recent opportunities tagged to this code show minimal direct activity for this specific opioid antagonist and instead reflect broader state and local pharmaceutical supply agreements. State and local governments buy generic and branded pharmaceuticals, over-the-counter products, and opioid-reversal agents through cooperative purchasing vehicles, direct manufacturer relationships, and county health department procurement. The issuing bodies include state health agencies, county health departments, and multistate cooperative purchasing alliances that aggregate demand across participating jurisdictions. Seminole County, Florida (a county health department) and the Texas Health and Human Services Commission (a state health agency) appear in the recent record; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by Minnesota's state procurement office, represents a pooled-purchasing model serving multiple state and local participants across participating states including Oregon.

Recent opportunities span Florida, Texas, and Minnesota with downstream reach to other states participating in cooperative agreements. Seminole County issued IFB 60459723LAS on June 30, 2026 (response deadline July 26, 2023) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, awarded on a fixed-fee basis with a two-year initial term and one-year renewal option. The Texas HHS Commission issued RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for direct-to-manufacturer prescription programs aimed at improving fulfillment efficiency and cost management outside traditional pharmacy benefit manager and group purchasing organization channels. MMCAP issued RFP S1070000015802 (response deadline March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products through three authorized wholesalers (AmerisourceBergen, Cardinal Health, and Morris & Dickson), with awarded vendors effective July 1, 2026, pricing weighted 75 percent in evaluation, and a two-year initial term for new responders.